Biological measure of compliance to Artesunate plus Amodiaquine association: Interest in a Mono-Desethyl-Amodiaquine blood assay?

Acta Tropica

Volumn 110, Issue 1, 2009, Pages 1-6

  Sarrassat, Sophie ^a   Sakho, Madiagne ^b   Hesran, Jean Yves Le ^a  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

Author keywords

Artesunate plus Amodiaquine; Blood assay; Compliance

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ANTIMALARIAL AGENT; ARSUCAM; DEETHYLAMODIAQUINE; DRUG METABOLITE; UNCLASSIFIED DRUG;

BIOASSAY; BLOOD; COMPARATIVE STUDY; CONCENTRATION (COMPOSITION); DISEASE TREATMENT; MALARIA;

ABDOMINAL PAIN; ADULT; ANOREXIA; ARTICLE; ASSAY; ASTHENIA; BLOOD SAMPLING; BODY WEIGHT; DIZZINESS; DOSAGE SCHEDULE COMPARISON; DRUG BLOOD LEVEL; DRUG DETERMINATION; FEMALE; HEADACHE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALARIA; MALARIA CONTROL; MALE; NAUSEA; NORMAL HUMAN; PATIENT COMPLIANCE; PRURITUS; REPEATED DRUG DOSE; SINGLE DRUG DOSE; VOMITING;

ADULT; AMODIAQUINE; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMBINATIONS; FEMALE; HUMANS; MALARIA; MALE; PATIENT COMPLIANCE; YOUNG ADULT;

ARTESUNATE;

EID: 61749093993     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2008.11.001     Document Type: Article

References (27)

1. Bergqvist Y., and Churchill F.C. Detection and determination of antimalarial drugs and their metabolites in body fluids. J. Chromatogr. 434 (1988) 1-20
2. Brasseur P., Agnamey P., Gaye O., Vaillant M., Taylor W.R.J., and Olliaro P.L. Efficacy and safety of artesunate plus amodiaquine in routine use for treatment of uncomplicated malaria in Casamance, southern Senegal. Malar. J. 6 (2007) 150
3. Dahan R., Dahan A., Cadranel J., and Caulin C. Compliance: measurement of adherence to treatment and therapeutic follow-up. Thérapie 40 (1985) 17-23
4. Depoortere E., Guthmann J.P., Sipilanyambe N., Nkandu E., Fermon F., Balkan S., and Legros D. Adherence to the combination of sulfadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia. Trop. Med. Int. Health 9 (2004) 62-67
5. Depoortere E., Guthmann J.P., Presse J., Sipilanyambe N., Nkandu E., Balkan S., De Pecoulas P.E., and Legros D. Efficacy and effectiveness of the combination of sulfadoxine/pyrimethamine and a 3-day course of artesunate for the treatment of uncomplicated falciparum malaria in a refugee settlement in Zambia. Trop. Med. Int. Health 10 (2005) 139-145
6. Feely M., Cooke J., Price D., Singleton S., Mehta A., Bradford L., and Calvert R. Low dose phenobarbitone as an indicator of compliance with drug therapy. Br. J. Clin. Pharmacol. 24 (1987) 77-83
7. Fogg C., Bajunirwe F., Piola P., Biraro S., Checchi F., Kiguli J., Namiiro P., Musabe J., Kyomugisha A., and Guthmann J.P. Adherence to a six dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. Am. J. Trop. Med. Hyg. 71 (2004) 525-530
8. Geary T.G., Akood M.A., and Jensen J.B. Characteristics of chloroquine binding to glass and plastic. Am. J. Trop. Med. Hyg. 32 (1983) 19-23
9. Gitau E.N., Muchohi S.N., Ogutu B.R., Githiga I.M., and Kokwaro G.O. Selective and sensitive liquid chromatographic assay of amodiaquine and desethylamodiaquine in whole blood spotted on filter paper. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 799 (2004) 173-177
10. Homedes N., and Ugalde A. Research on patient compliance in developing countries. Bull. Pan. Am. Health Organ. 28 (1994) 17-33
11. Idowu O.R. Detection and estimation of antimalarial drugs in body fluids. I. Field test for amodiaquine in urine and saliva. J. Pharm. Biomed. Anal. 5 (1987) 591-596
12. Jewell H., Maggs J.L., Harrison A.C., O'Neill P.M., Ruscoe J.E., and Park B.K. Role of hepatic metabolism in bioactivation and detoxication of amodiaquine. Xenobiotica 25 (1995) 199-217
13. Kachur S.P., Khatib R.A., Kaizer E., Fox S.S., Abdulla S.M., and Bloland P.B. Adherence to antimalarial therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania. Am. J. Trop. Med. Hyg. 71 (2004) 715-722
14. Karbwang J., and White N.J. Clinical pharmacokinetics of mefloquine. Clin. Pharmacokinet. 19 (1990) 264-279
15. Karbwang J., Fungladda W., Pickard C.E., Shires S., Hay A., and Feely M. Initial evaluation of low dose phenobarbital as an indicator of compliance with antimalarial drug treatment. Bull. WHO 76 Suppl. 1 (1998) 67-73
16. Kroeger A. Health interview surveys in developing countries: a review of the methods and results. Int. J. Epidemiol. 12 (1983) 465-481
17. Meshnick S.R., Taylor T.E., and Kamchonwongpaisan S. Artemisinin and the antimalarial endoperoxides: from herbal to targeted chemotherapy. Microbiol. Rev. 60 (1996) 301-315
18. Na-Bangchang K., Congpuong K., Sirichaisinthop J., Suprakorb K., and Karbwang J. Compliance with a 2 day course of artemether-mefloquine in an area of highly multi drug resistant Plasmodium falciparum malaria. Br. J. Clin. Pharmacol. 43 (1997) 639-642
19. Orrell C., Little F., Smith P., Folb P., Taylor W., Olliaro P., and Barnes K.I. Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers. Eur. J. Clin. Pharmacol. (2008) [Epub ahead of print]
20. Pearson R.M. Who is taking their tablets?. Br. Med. J. 285 (1982) 757-758
21. Price R.N., and Nosten F. Drug resistant falciparum malaria: clinical consequences and stratégies for prevention. Drug Resist. Updat. 4 (2001) 187-196
22. Pullar T., Kumar S., Tindall H., and Feely M. Time to stop counting the tablets?. Clin. Pharmacol. Ther. 46 (1989) 163-168
23. Pussard E., Verdier F., Faurisson F., Scherrmann J.M., Le Bras J., and Blayo M.C. Disposition of Monodesethylamodiaquine after a single oral dose of Amodiaquine and three regimens for prophylaxis against Plasmodium falciparum malaria. Eur. J. Clin. Pharmacol. 33 (1987) 409-414
24. Shwe T., Lwin M., and Aung S. Influence of blister packaging on the efficacy of artesunate + mefloquine over artesunate alone in community based treatment of non severe falciparum malaria in Myanmar. Bull. WHO 76 Suppl. 1 (1998) 35-41
25. Teja-Isavadharm P., Watt G., Eamsila C., Jongsakul K., Li Q., Keeratithakul G., Sirisopana N., Luesutthiviboon L., Brewer T.G., and Kyle D.E. Comparative pharmacokinetics and effect kinetics of orally administered artesunate in healthy volunteers and patients with uncomplicated falciparum malaria. Am. J. Trop. Med. Hyg. 65 (2001) 717-721
26. Winstanley P., Edwards G., Orme M., and Breckenridge A. The disposition of amodiaquine in man after oral administration. Br. J. Clin. Pharmacol. 23 (1987) 1-7
27. Winstanley P.A., Simooya O., Kofi-Ekue J.M., Walker O., Salako L.A., Edwards G., Orme M.L., and Breckenridge A.M. The disposition of amodiaquine in Zambians end Nigerians with malaria. Br. J. Clin. Pharmacol. 29 (1990) 695-701